Clinical Trials Sponsored by Toragen, Inc.

Total 35767 results

Toragen, Inc.

Recruiting

Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer

HPV Associated Cancers

United States
Tocagen Inc.

Completed

A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma

Glioblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

United States
Tocagen Inc.

Withdrawn

A Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care (Toca7)

Newly Diagnosed High Grade Glioma (HGG)
Tocagen Inc.

Terminated

A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)

Melanoma | Sarcoma | Lymphoma | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | IDH1 Mutated Solid Tumors | IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)

United States
Tocagen Inc.

Completed

Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

Glioblastoma Multiforme | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

United States
Tocagen Inc.

Completed

Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Glioblastoma Multiforme | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

United States
Tocagen Inc.

Withdrawn

A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8)

Bladder Cancer
Tocagen Inc.

Terminated

A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

Astrocytoma | Glioblastoma Multiforme | Gliomas, Malignant

United States
Tocagen Inc.

Terminated

The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma (Toca5)

Glioblastoma Multiforme | Anaplastic Astrocytoma

United States, Korea, Republic of, Canada, Israel
Theragen Inc.

Completed

Controlled Study of Kneehab XP for Patients Undergoing Total Knee Replacement

Total Knee Replacement

United States
miRagen Therapeutics, Inc.

Terminated

SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides (SOLAR)

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

United States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
miRagen Therapeutics, Inc.

Completed

Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids

Keloid

United States
miRagen Therapeutics, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MRG-110 Following Intradermal Injection in Healthy Volunteers

Healthy Volunteer

United States
miRagen Therapeutics, Inc.

Terminated

PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (PRISM)

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

United States, France, Belgium
miRagen Therapeutics, Inc.

Completed

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Chronic Lymphocytic Leukemia (CLL) | Cutaneous T-cell Lymphoma (CTCL) | Mycosis Fungoides (MF) | Diffuse Large B-Cell Lymphoma (DLBCL), ABC Subtype | Adult T-Cell Leukemia/Lymphoma (ATLL)

United States
miRagen Therapeutics, Inc.

Completed

Safety, Tolerability and Pharmacokinetic Study of MRG-201 in Healthy Volunteers

Healthy Volunteers

Canada
Orfagen

Completed

Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)

Idiopathic Solar Urticaria

United States, United Kingdom
Covagen

Terminated

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

Germany
Orfagen

Completed

Efficacy, Local Tolerance and Patient Acceptability of a Moisturizing Emollient in Patients With Uremic Xerosis

Uremic Xerosis
Orfagen

Completed

Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis

Uremic Xerosis
Kreiskrankenhaus Dormagen

Recruiting

Evaluation of the New Acceleromyograph TOF 3D

Neuromuscular Block | Assessment of a New Acceleromyograph

Germany
Kreiskrankenhaus Dormagen

Completed

Influence of Neuromuscular Block on Mask Ventilation

Effect of a Neuromuscular Block on Ventilation

Germany
Kreiskrankenhaus Dormagen

Completed

Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty

Pain | Total Knee Arthroplasty

Germany
Kreiskrankenhaus Dormagen

Completed

Influence of Analgesia and Neuromuscular Block on Abdominal Distension and Operating Conditions Laparoscopic Operations

Neuromuscular Blockade

Germany
Stragen France

Completed

First-In-Human PainCart Study for STR-324

Pain

Netherlands
Kreiskrankenhaus Dormagen

Completed

Accelerometry at the Neck: Comparison With m. Adductor Pollicis Stimulation

Feasibility of Measurement of a Neuromuscular Block at the m. Trapezius

Germany
Zomagen Biosciences, Ltd

Completed

A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore)

Cryopyrin Associated Periodic Syndrome

United States
Oxagen Ltd

Completed

OC000459 Dose Finding Study in Hay Fever Sufferers.

Allergic Rhinitis

Austria
Kreiskrankenhaus Dormagen

Completed

Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium

Neuromuscular Block, Dexamethasone | Neuromuscular Block, Recovery

Germany
Oxagen Ltd

Completed

Proof of Concept Study of OC000459 in Eosinophilic Esophagitis

Eosinophilic Esophagitis

Switzerland
Oxagen Ltd

Completed

A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis

Allergic Rhinitis

Austria
Oxagen Ltd

Completed

OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma

Mild to Moderate Persistent Asthma

Bulgaria, Russian Federation, Hungary, Romania, Ukraine, Poland
Oxagen Ltd

Completed

Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4

Healthy Volunteers

United Kingdom
Oxagen Ltd

Completed

Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects

Asthma

Russian Federation
CuraGen Corporation

Completed

Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant

Stomatitis

United States
CuraGen Corporation

Completed

Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United States
AuraGen Aesthetics LLC

Terminated

Prospective Comparison of Revolve™ and AuraGen 123 With AuraClens™ in Autologous Fat Grafting to the Breast

Autologous Fat Grafting

United States
CuraGen Corporation

Completed

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Stomatitis | Oral Mucositis

United States
CuraGen Corporation

Completed

A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

Unresectable Stage III or Stage IV Melanoma

United States
University Research Foundation for Lysosomal Storage...
University of Pittsburgh

Completed

Validating a New Severity Score System for Adults With Type 1 Gaucher Disease (GD1)

Gaucher Disease

United States
Ayşe Toraman

Not yet recruiting

Factors Affecting Kinesiophobia in the Elderly

Aged

Turkey
Ayşe Toraman

Recruiting

The Effect of Backward Walking Training in the Elderly

Elderly People

Turkey
Orfagen
FDA Office of Orphan Products Development

Completed

Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.

Congenital Venous Malformation

United States, France
Torben Brøchner Pedersen

Completed

Predicting Prostate Biopsy Results With Biomarkers and mpMRI. (ProBioM)

Prostate Cancer

Denmark
113 Suicide Prevention
Orygen; Mind

Recruiting

Chatsafe Netherlands: Improving Safe Suicide Communication for Young People on Social Media (CSNL)

Communication | Social Media | Suicide Prevention

Netherlands
Torben Pottgiesser

Recruiting

Risk Stratification Post TAVI Using TEG (RISTRATAVI)

Cardiovascular Diseases | Thrombosis | Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement | Predictive Value of Tests | Thrombelastography | Platelet Function Tests

Germany
Jorgen Vestbo

Withdrawn

Vitamin D and Chronic Obstructive Lung Disease

Chronic Obstructive Lung Disease

Denmark
St. Luke's International Hospital, Japan
Trigen

Not yet recruiting

Feedback Using behaviOral econOmic Theories on STEP countS in Cardiovascular Disease Patients (FOOTSTEPS)

Cardiovascular Diseases | Rehabilitation | Behavioral Economics
Torben Harsløf
Odense University Hospital

Active, not recruiting

Glucocorticoids and Bone in Graves' Ophthalmopathy

Graves Ophthalmopathy

Denmark
Lars Borgen
Sykehuset Buskerud HF

Completed

Enhancement and Restoring of Low Dose Abdominal CT Images

Radiation Protection

Norway

Clinical Trials Sponsored by Toragen, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations